These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 361528)

  • 1. [Predisposing factors in candidiasis. Animal experimental studies and clinical findings with special regard to immunity].
    Fegeler KJ
    Fortschr Med; 1978 Nov; 96(42):2169-72. PubMed ID: 361528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Predisposing factors in candidiasis].
    Nolting S; Fegeler K
    Z Hautkr; 1979 Jan; 54(2):58-64. PubMed ID: 760324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased susceptibility of TNF-alpha lymphotoxin-alpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans.
    Netea MG; van Tits LJ; Curfs JH; Amiot F; Meis JF; van der Meer JW; Kullberg BJ
    J Immunol; 1999 Aug; 163(3):1498-505. PubMed ID: 10415052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Animal experiment studies on immunity in infection with Candida albicans (part 2 and conclusion)].
    Fegeler K; Macher E; Nolting S
    Mykosen; 1978 Jul; 21(7):201-22. PubMed ID: 355875
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro immunity of rat peritoneal macrophages to Candida albicans.
    Joshi KR; Joshi H
    Indian J Chest Dis Allied Sci; 2000; 42(4):341-4. PubMed ID: 15597683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas-FasL interactions modulate host defense against systemic Candida albicans infection.
    Netea MG; van Der Meer JW; Meis JF; Kullberg BJ
    J Infect Dis; 1999 Nov; 180(5):1648-55. PubMed ID: 10515828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulation in response to Candida.
    Domer JE; Garner RE
    Immunol Ser; 1989; 47():293-317. PubMed ID: 2490080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose of Concanavalin-A enhances innate immune response and prevents liver injury in mice infected with Candida albicans.
    Conchon-Costa I; Loyola W; Gaziri LC; Custódio LA; Felipe I
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):330-6. PubMed ID: 17284281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated model of the recognition of Candida albicans by the innate immune system.
    Netea MG; Brown GD; Kullberg BJ; Gow NA
    Nat Rev Microbiol; 2008 Jan; 6(1):67-78. PubMed ID: 18079743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host resistance to Candida albicans infection of mice with collagen-induced arthritis treated with leflunomide.
    Dimitrova P; Ivanovska N
    Res Microbiol; 2006; 157(6):525-30. PubMed ID: 16797932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of thymus-dependent cell-mediated immunity in resistance to experimental disseminated candidiasis.
    Rogers TJ; Balish E; Manning DD
    J Reticuloendothel Soc; 1976 Oct; 20(4):291-8. PubMed ID: 994127
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immune responses of mice in experimental Candida infection: the influence of canditoxin on activity of lymphoid cells [proceedings].
    Uchida K; Iwata K
    Jpn J Med Sci Biol; 1978 Apr; 31(2):195-7. PubMed ID: 355686
    [No Abstract]   [Full Text] [Related]  

  • 13. Active and passive immunization against oral Candida albicans infection in a murine model.
    Farah CS; Ashman RB
    Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of innate immunity in resistance to Candida albicans.
    Tuite A; Mullick A; Gros P
    Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene targeting demonstrates that inducible nitric oxide synthase is not essential for resistance to oral candidiasis in mice, or for killing of Candida albicans by macrophages in vitro.
    Farah CS; Saunus JM; Hu Y; Kazoullis A; Ashman RB
    Oral Microbiol Immunol; 2009 Feb; 24(1):83-8. PubMed ID: 19121076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Host defense mechanisms in systemic candidiasis (author's transl)].
    Schütte H; Lazo M; Ferrada L
    Rev Med Chil; 1981 Apr; 109(4):349-53. PubMed ID: 7034112
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to Candida albicans: Th1, Th2 cells and beyond.
    Romani L
    Curr Opin Microbiol; 1999 Aug; 2(4):363-7. PubMed ID: 10458979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular immunity in patients sensitized to Candida albicans and its corresponding humoral response.
    Oehling A; Crisci CD; Subirá ML; Jerez J
    Allergol Immunopathol (Madr); 1976; 4(5):333-44. PubMed ID: 795291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to fungal infections.
    Blanco JL; Garcia ME
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):47-70. PubMed ID: 18565595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.